Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: Insights from the VIVID registry

Henrique B. Ribeiro, Josep Rodés-Cabau, Philipp Blanke, Jonathon Leipsic, Jong Kwan Park, Vinayak Bapat, Raj Makkar, Matheus Simonato, Marco Barbanti, Joachim Schofer, Sabine Bleiziffer, Azeem Latib, David Hildick-Smith, Patrizia Presbitero, Stephan Windecker, Massimo Napodano, Alfredo G. Cerillo, Mohamed Abdel-Wahab, DIdier Tchetche, Claudia FiorinaJan Malte Sinning, Mauricio G. Cohen, Mayra E. Guerrero, Brian Whisenant, Fabian Nietlispach, José Honório Palma, Luis Nombela-Franco, Arend De Weger, Malek Kass, Fabio Sandoli De Brito, Pedro A. Lemos, Ran Kornowski, John Webb, Danny Dvir

Research output: Contribution to journalArticle

83 Scopus citations

Abstract

Aims There are limited data on coronary obstruction following transcatheter valve-in-valve (ViV) implantation inside failed aortic bioprostheses. The objectives of this study were to determine the incidence, predictors, and clinical outcomes of coronary obstruction in transcatheter ViV procedures. Methods and results A total of 1612 aortic procedures from the Valve-in-Valve International Data (VIVID) Registry were evaluated. Data were subject to centralized blinded corelab computed tomography (CT) analysis in a subset of patients. The virtual transcatheter valve to coronary ostium distance (VTC) was determined. A total of 37 patients (2.3%) had clinically evident coronary obstruction. Baseline clinical characteristics in the coronary obstruction patients were similar to controls. Coronary obstruction was more common in stented bioprostheses with externally mounted leaflets or stentless bioprostheses than in stented with internally mounted leaflets bioprostheses (6.1% vs. 3.7% vs. 0.8%, respectively; P < 0.001). CT measurements were obtained in 20 (54%) and 90 (5.4%) of patients with and without coronary obstruction, respectively. VTC distance was shorter in coronary obstruction patients in relation to controls (3.24 ± 2.22 vs. 6.30 ± 2.34, respectively; P < 0.001). Using multivariable analysis, the use of a stentless or stented bioprosthesis with externally mounted leaflets [odds ratio (OR): 7.67; 95% confidence interval (CI): 3.14-18.7; P < 0.001] associated with coronary obstruction for the global population. In a second model with CT data, a shorter VTC distance predicted this complication (OR: 0.22 per 1 mm increase; 95% CI: 0.09-0.51; P < 0.001), with an optimal cut-off level of 4 mm (area under the curve: 0.943; P < 0.001). Coronary obstruction was associated with a high 30-day mortality (52.9% vs. 3.9% in the controls, respectively; P < 0.001). Conclusion Coronary obstruction following aortic ViV procedures is a life-threatening complication that occurred more frequently in patients with prior stentless or stented bioprostheses with externally mounted leaflets and in those with a short VTC.

Original languageEnglish (US)
Pages (from-to)687-695
Number of pages9
JournalEuropean heart journal
Volume39
Issue number8
DOIs
StatePublished - Feb 21 2018

Keywords

  • Coronary obstruction
  • Coronary occlusion
  • Prior surgical bioprosthesis
  • Transcatheter aortic valve replacement
  • Valve-in-valve

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: Insights from the VIVID registry'. Together they form a unique fingerprint.

  • Cite this

    Ribeiro, H. B., Rodés-Cabau, J., Blanke, P., Leipsic, J., Kwan Park, J., Bapat, V., Makkar, R., Simonato, M., Barbanti, M., Schofer, J., Bleiziffer, S., Latib, A., Hildick-Smith, D., Presbitero, P., Windecker, S., Napodano, M., Cerillo, A. G., Abdel-Wahab, M., Tchetche, DI., ... Dvir, D. (2018). Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: Insights from the VIVID registry. European heart journal, 39(8), 687-695. https://doi.org/10.1093/eurheartj/ehx455